Recurrence and postoperative quality of life after surgical resection of unilateral cT1–T3N1bM0 papillary thyroid carcinoma

Zhilin Qiu,Liang Zhang,Xi Guo,Zhaoming Ding,Jihua Han,Wen Bi,Bing Sun,Jiewu Zhang,Chunlei Nie

DOI: https://doi.org/10.21037/gs-24-178

2024-10-30

Gland Surgery

Abstract:Keywords: Papillary thyroid carcinoma (PTC); extent of surgery; complications; postoperative quality of life

surgery

What problem does this paper attempt to address?

Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer

Siyuan Xu,Hui Huang,Huilei Dong,Xiaolei Wang,Zhengang Xu,Shaoyan Liu,Jie Liu

DOI: https://doi.org/10.1186/s12885-023-11307-1

IF: 4.638

2023-09-20

BMC Cancer

Abstract:Guidelines recommend total thyroidectomy (TT) to facilitate radioactive ablation and serological follow-up for intermediate- to high-risk papillary thyroid carcinoma (PTC). However, the association between surgical extent and tumor recurrence in these patients has not been well validated. We aimed to examine the association between the extent of surgery and recurrence in patients with completely resected unilateral intermediate- to high-risk PTC.

oncology
Clinical features and prognosis of patients with benign thyroid disease accompanied by an incidental papillary carcinoma.

Shi-Fu Wang,Wen-He Zhao,Wei-Bin Wang,Xiao-Dong Teng,Li-Song Teng,Zhi-Min Ma

DOI: https://doi.org/10.7314/APJCP.2013.14.2.707

2013-01-01

Asian Pacific Journal of Cancer Prevention

Abstract:Purpose: To investigate the clinical features and prognosis of papillary thyroid carcinoma (PTC) with a background of benign disease. Method: A total of 709 patients with papillary thyroid carcinoma undergoing surgical resection were analyzed retrospectively. In 147 patients who underwent surgery for benign thyroid disease, incidental PTC (IPC group) were identified by intraoperative or postoperative pathological examination of surgical specimens but were not detected by preoperative imaging studies. In the other group, according to the pathological examination with or without co-existing benign thyroid disease, 253 cases were clarified as concomitant PTC and 309 cases were clarified as dominant PTC. Results: Incidental PTC was more common in women, about 85.7%, the mean age was 47.6 +/- 11.3 years old. Average tumor diameter was 4.4 +/- 2.2 mm, multiple lesions accounted for 12.9% (19/147), and the cervical lymph node metastasis rate was 6.1% (9/147). After radical resection 8 cases recurred, the median time of recurrence was about 12 months (0.5 to 162), there was no tumor-related death. The tumor-free survival rates were 97.3%, 95.9%, 91.5%, and 79.3% in 1, 5, 10 and 14 year respectively. Conclusion: Incidental PTC with a background of benign lesions is common, and the generally good prognosis can be attributed to tumor early detection and early treatment. On the intraoperative finding of incidental PTC, lobectomy (unilateral) or total thyroidectomy (bilateral) should be the first choice, but with a postoperative pathologic finding of incidental PTC, further treatment, such as completion thyroidectomy or immediate lymph dissection is not necessary. Central lymph node dissection is also not needed unless lymphadenectasis is present.
The outcomes and prognostic factors in patients after reoperation of persistent/recurrent papillary thyroid carcinoma

Wenyu Sun,Lu Di,Lili Chen,Duanshu Li,Yi Wu,Jun Xiang,Shichong Zhou,Tuanqi Sun

DOI: https://doi.org/10.21203/rs.3.rs-1851573/v1

2022-01-01

Abstract:Abstract Background: The most suitable approach for the treatment of recurrent papillary thyroid carcinoma (PTC) remains controversial and reoperation may be an effective method. The efficacy of reoperation in these patients with locoregional recurrence, especially the ones with unsatisfying efficacy of radioactive iodine ablation, is still uncertain. This study aimed to clarify clinical management strategies for locoregional recurrence of PTC and to explore factors that may affect long-term patient outcomes after reoperation.Methods: In total, 124 patients who initially underwent thyroidectomy and variable extents of RAI therapy and finally received reoperation for locoregionally recurrent PTC, were included. Parameters associated with recurrence-free survival (RFS) were analyzed using a Cox proportional hazards model.Results: Thirty-two patients had secondary clinical recurrence after reoperation during follow-up. Metastatic lymph nodes with extra-nodal extension (P=0.023) and high post-reoperative (post-reop) unstimulated thyroglobulin (unstim-Tg) levels (P=0.001) were independent prognostic factors for recurrence-free survival. Neither the avidity of RAI nor the frequency and dose of RAI therapies before reoperation affected long-term outcome.Conclusions: Patients with locoregionally recurrent PTC rarely benefit from additional RAI therapy before reoperation, and surgical intervention should be prioritized in the clinical management of locoregionally recurrent PTC. Metastatic lymph nodes with extra-nodal extension and post-reop unstim-Tg >10.1 ng/mL may have a poor prognosis.
Status of mental and social activities of young and middle-aged patients after papillary thyroid cancer surgery

Songhao Chen,Xi'e Hu,Ping Yang,Lin Yang,Shujia Peng,Li He,Lijuan Yuan,Guoqiang Bao

DOI: https://doi.org/10.3389/fonc.2024.1338216

IF: 4.7

2024-03-27

Frontiers in Oncology

Abstract:Background: Papillary thyroid cancer (PTC) is prevalent among younger populations and has a favorable survival rate. However, a significant number of patients experience psychosocial stress and a reduced quality of life (QoL) after surgical treatment. Therefore, comprehensive evaluations of the patients are essential to improve their recovery. Methods: The present study enrolled 512 young and middle-aged patients diagnosed with PTC who underwent surgery at our institution between September 2020 and August 2021. Each participant completed a series of questionnaires: Generalized Anxiety Disorder 7 (GAD-7), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), Thyroid Cancer-Specific Quality of Life Questionnaire (THYCA-QoL), and Readiness to Return-to-Work Scale (RRTW). Results: GAD-7 data showed that almost half of the study subjects were experiencing anxiety. Regarding health-related quality of life (HRQoL), participants reported the highest levels of fatigue, insomnia, voice problems, and scarring, with patients in anxious states reporting worse symptoms. Based on RRTW, more than half of the subjects had returned to work and had better HRQoL compared to the others who were evaluating a possible return to work. Age, gender, BMI, education, diet, residence, health insurance, months since surgery, monthly income, and caregiver status were significantly correlated with return to work. Additionally, having a caregiver, higher monthly income, more time since surgery, and living in a city or village were positively associated with return to work. Conclusion: Young and middle-aged patients with PTC commonly experience a range of health-related issues and disease-specific symptoms following surgery, accompanied by inferior psychological well-being, HRQoL, and work readiness. It is crucial to prioritize timely interventions targeting postoperative psychological support, HRQoL improvement, and the restoration of working ability in PTC patients.

oncology
The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma

Wenyu Sun,Lu Di,Lili Chen,Duanshu Li,Yi Wu,Jun Xiang,Shichong Zhou,Tuanqi Sun

DOI: https://doi.org/10.1186/s12893-022-01819-1

2022-01-01

BMC Surgery

Abstract:Background While the most suitable approach for treating persistent/recurrent papillary thyroid carcinoma (PTC) remains controversial, reoperation may be considered an effective method. The efficacy of reoperation in patients with locoregional persistent/recurrent PTC, especially those with unsatisfactory radioactive iodine (RAI) ablation results, is still uncertain. This study aimed to clarify the clinical management strategies for locoregional persistent/recurrent PTC and to explore factors that may affect long-term patient outcomes after reoperation. Methods In total, 124 patients who initially underwent thyroidectomy and variable extents of RAI therapy and finally received reoperation for locoregionally persistent/recurrent PTC were included. The parameters associated with recurrence-free survival (RFS) were analysed using a Cox proportional hazards model. Results Overall, 124 patients presented with structural disease after initial therapy and underwent secondary surgical resection, of whom 32 patients developed further structural disease during follow-up after reoperation. At the time of reoperation, metastatic lymph nodes with extranodal extension ( P = 0.023) and high unstimulated thyroglobulin (unstim-Tg) levels after reoperation (post-reop) ( P = 0.001) were independent prognostic factors for RFS. Neither RAI avidity nor the frequency and dose of RAI therapies before reoperation affected RFS. Conclusions Reoperation is an ideal clinical treatment strategy for structural locoregional persistent/recurrent PTC, and repeated empirical RAI therapies performed prior to reoperation may not contribute to the long-term outcomes of persistent/recurrent PTC patients. Metastatic lymph nodes with extranodal extension and post-reop unstim-Tg > 10.1 ng/mL may predict a poor prognosis.
Analysis of Risk Factors Contributing to Recurrence of Papillary Thyroid Carcinoma in Chinese Patients Who Underwent Total Thyroidectomy

Wei Zhang,De Jiao,Baoguo Liu,Shanping Sun

DOI: https://doi.org/10.12659/msm.895564

2016-01-01

Medical Science Monitor

Abstract:BACKGROUND Thyroid cancer is a very common endocrine malignancy, with a rate of total thyroidectomy reported to be up to 27.8%. However, studies analyzing the risk factors that contribute to recurrence of papillary thyroid carcinoma (PTC) after total thyroidectomy in China are still scarce. MATERIAL AND METHODS A total of 536 patients with PTC who underwent total thyroidectomy were retrospectively analyzed. Patients were divided into 2 groups: patients with no recurrent tumor were included in group 1 and patients with tumor recurrence were included in group 2. RESULTS Of 536 patients, 65 patients (12.1%) developed a recurrence of PTC, and 471 patients (87.9%) did not have a recurrence. Univariate analysis indicated that male sex, age ≥50 years, tumor ≥1 cm, poor differentiation, lymph node metastasis, bilaterality, and multifocality may be related to PTC recurrence. Additionally, the results of the logistic regression analysis indicated that male sex, age ≥50 years, primary tumor ≥1 cm, poor dedifferentiation of the tumor, lymph node metastasis, and multifocality may be independent factors contributing to PTC recurrence. CONCLUSIONS Male sex, age more than 50 years, primary tumor larger than 1 cm, poor dedifferentiation of the primary tumor, lymph node metastasis, and multifocality were found to increase the risk of PTC recurrence in patients who underwent total thyroidectomy. Additionally, it is necessary to use strictly aggressive and extensive surgery, as well as close monitoring, after the operation.
Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan

Jui-Hung Sun,Yan-Rong Li,Kuo-Hsuan Chang,Miaw-Jene Liou,Shu-Fu Lin,Sung-Sheng Tsai,Ming-Chin Yu,Chuen Hsueh,Szu-Tah Chen

DOI: https://doi.org/10.1016/j.bj.2021.11.009

IF: 5.5

2021-11-01

Biomedical Journal

Abstract:BACKGROUND: Many patients with papillary thyroid cancer (PTC) demonstrate satisfactory outcomes. However, 8%-28% of patients with PTC show tumor recurrence, which may affect prognosis. Therefore, identifying factors associated with tumor recurrence in patients with PTC may be helpful to refine therapeutic strategies.METHODS: To identify factors associated with PTC recurrence, we retrospectively reviewed demographic features (sex and age), operation method, image character, serum thyroglobulin (Tg), accumulated radioactive iodine (I-131) therapeutic dose, I-131 uptake, and metastases at diagnosis in 829 patients with PTC. Patients were grouped into early (stage I and II; n = 698) and advanced (stage III and IV; n = 131) tumor-node-metastasis (TNM) stages. Recurrence rate, mortality rate, risk factors of recurrence, recurrent free survival and overall survival curve were compared between two groups.RESULTS: Patients in the early stage demonstrated a lower recurrence rate (7.2%) than did those in the advanced stage (28.2%, p < 0.05). The mortality rate of patients with recurrence in the advanced stage was higher than that of those in the early stage (51.4% vs. 12.0%). The major impact factors on tumor recurrence in early TNM stage were distant metastasis and lymph node metastasis, while in advanced TNM stage were distant metastasis, male gender, total thyroidectomy with limited lymph node dissection, and a high serum Tg level.CONCLUSIONS: Strategies to monitor tumor recurrence might be refined according to the TNM stages of PTC patients.

biochemistry & molecular biology,medicine, research & experimental
Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study

Qing Zhang,Zhen-Zhu Zhong,Tian Wu and Yuan-Qiang He

DOI: https://doi.org/10.1186/s12893-024-02426-y

2024-05-03

BMC Surgery

Abstract:While surgery plays a crucial role in treating papillary thyroid carcinoma (PTC), the potential effects of subsequent TSH suppression therapy on prognosis should not be overlooked. This study aims to investigate the factors that influence postoperative TSH suppression therapy in patients with PTC.

surgery
Quality of Life in Patients with Liver Cancer after Operation:A 2-Year Follow-Up Study

Li Chen,Yong Liu,Guo-Gang Li,Si-Feng Tao,Yuan Xu,Hua Tian

2004-01-01

Abstract:BACKGROUND:Quality of life (QL) is a concept which reflects the physical, social, and emotional attitudes and behaviours of an individual. QL assessment is becoming increasingly recognised as an outcome and predictor for cancer patients. Although hepatectomy has been widely accepted as treatment of choice to offer a chance of cure for patients with liver cancer, little is known about the subjective clinical results after this operation. This prospective study was designed to evaluate the Pre- and postoperative quality of life in patients with liver cancer. METHODS:The quality of life of 36 consecutive patients was measured using gastrointestinal quality of life index (GQLI) regularly 2 years after the operation, starting with a preoperative measurement. RESULTS:The score of mean preoperative GQLI was 106+/-13 points, and it was reduced significantly 2-10 weeks after the operation (86-98) (P<0.05-0.001). The quality of life recovered gradually. The GQLI score was 101+/-21 points 4 months after operation and increased to the preoperative level (P>0.05). In the patients who survived more than 9 months, the GQLI score was higher than that before the operation. Major hepatectomy (lobectomy and combined segmentectomy) reduced the GQLI score more evidently than did minor hepatectomy (simple segmentectomy) in 2-5 weeks after the operation (P<0.05). The age and preoperative liver function of the patients played an important role in the recovery of the quality of life in the early postoperative stage (P<0.05). The patients with tumor recurrence showed a continuous decrease of the quality of life (P<0.05-0.001). CONCLUSIONS:The assessment of the quality of life is meaningful for patients with liver cancer. Tumor recurrence, poor liver function and major operation are the most important factors for reducing the quality of life. Hepatic resection is justified by its effects on the survival and the quality of life of the patients.
Transition Analysis in the Clinicopathology and Prognosis of 2 682 Papillary Thyroid Carcinoma Cases over a 15-Year Period

Wang Weibin,Su Xingyun,Ruan Jiaying,Mao Zhuochao,He Kuifeng,Wang Min,Wu Fusheng,Zhou Donghui,Sheng Jianming,Li Zhongqi,Yu Xiongfei,Lu Yimin,Wang Haiyong,Teng Xiaodong,Zhao Wenhe,Ma Zhimin,Teng Lisong

DOI: https://doi.org/10.3760/cma.j.issn.1007-631x.2018.05.009

2018-01-01

Abstract:Objective To evaluate the change of clinicopathological features and prognosis of papillary thyroid cancer over a 15-year period.Methods The clinicopathological features and outcomes of papillary thyroid cancer patients were analyzed in three groups according to the time of diagnosis:group Ⅰ (1997-2001),group Ⅱ (2002-2006),and group Ⅲ (2007-2011).Results As time advanced,the average age of papillary thyroid cancer patients increased,tumor stage,like size,extrathyroid invasion and lymph node metastasis decreased dramatically (P ＜ 0.01).The percentage of multifocality and bilaterality increased.The long-term follow up data (median follow up time was 6.6 years),indicated that the 15-year over all survival was 97.8％ and the 15-year disease-free survival was 90.2％.Tumor ≥3 cm,bilaterality,extrathyroid invasion,lymph node metastasis and AJCC stage were correlated with tumor recurrence.By multivariate COX-regression analysis only lymph node metastasis and bilaterality were independent risk factors.Conclusion The clinicopathological features of papillary thyroid cancer changed over 15 years,with the percentage of early-staged patients increased.Lymph node metastasis and bilaterality are two risk factors for tumor recurrence.
Evaluating the risk of re-recurrence in patients with persistent/recurrent thyroid carcinoma after initial reoperation

Siyuan Xu,Qingfeng Li,Zhiqi Wang,Hui Huang,Xiaolei Wang,Shaoyan Liu,Jie Liu

DOI: https://doi.org/10.1016/j.surg.2020.09.033

IF: 4.348

2021-04-01

Surgery

Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Although the 2015 American Thyroid Association guidelines proposed initial and response-to-therapy risk stratifications were adequately validated in untreated papillary thyroid cancer patients, it is still unknown how they work in persistent/recurrent papillary thyroid cancer patients. This study aimed to evaluate and revise the stratifications in these patients.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>This retrospective study included patients who received the first reoperation with complete thyroid resection but without radioactive iodine ablation. Stratifications were performed considering the persistent/recurrent tumor characteristics and thyroglobulin levels 1 to 6 months after reoperation and then revised with new prognostic factors and adjusted thyroglobulin cutoff values, respectively. Prognostic performance was evaluated with Kaplan-Meier curves, proportion of variation explained, and Harrell's concordance index.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Among a total of 232 patients, 5-year re-recurrence free survival rates were 92.4%, 86.2%, and 74.5% in low-, intermediate-, and high-risk patients, respectively (all <em>P</em> > .05) and 97.0%, 96.3%, and 81.6% in excellent response, intermediate response, and biochemical incomplete response groups, respectively (excellent response versus intermediate response, <em>P</em> > .05; intermediate response versus biochemical incomplete response, <em>P</em> < .05). After incorporating age at reoperation, recurrent primary size, and recurrent lymph node number, the high-risk group had significantly compromised re-recurrence free survival versus the intermediate-risk group (76.2% vs 91.6%). After adjusting thyroglobulin values, 5-year re-recurrence free survival rates were 96.4%, 85.9%, and 75.8% in excellent response (<1 ng/mL), intermediate response (1–10 ng/mL), and biochemical incomplete response (≥10 ng/mL) groups, respectively (all <em>P</em> < .05), with a higher proportion of variation explained (12.8% vs 10.1%) and concordance index (0.669 vs 0.615) compared with the American Thyroid Association version.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>The revised American Thyroid Association initial and response-to-therapy risk stratifications have acceptable predictive value for persistent/recurrent papillary thyroid cancer patients.</p>

surgery
Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis

Chao Qin,Sijia Cai,Yanyu Qi,Meilin Liu,Weibo Xu,Min Yin,Haitao Tang,Qinghai Ji,Tian Liao,Yu Wang

DOI: https://doi.org/10.3389/fendo.2024.1453601

2024-08-08

Abstract:Background: The presence of lymph node metastasis (LNM) is frequently observed in papillary thyroid carcinoma (PTC), and most clinical guidelines recommend total thyroidectomy. However, the impact of LNM on specific types of locoregional recurrence remains uncertain, particularly for stage T1 PTC. Methods: The present retrospective cohort study enrolled patients diagnosed with stage T1 PTC between 2008 and 2015. Propensity score matching was performed in patients with lobectomy accompanied by varying degrees of LNM. Logistic regression analysis was performed to compare the effect of LNM on relapse types, and Kaplan-Meier method was utilized to calculate recurrence-free survival. Results: The study cohort comprised 2,785 patients who were followed up for an average duration of 69 months. After controlling follow-up time and potential prognostic factors, we include a total of 362 patients in each group. Recurrence rates in the N0, N1a, and N1b groups were found to be 2.5%, 9.7%, and 10.2% respectively. Notably, group N1a versus group N0 (P=0.803), N1b group versus N0 group (P=0.465), and group N1b versus group N1a (P=0.344) had no difference in residual thyroid recurrence. However, when considering lymph node recurrence, both N1a(P=0.003) and N1b(P=0.009) groups showed a higher risk than N0 group. In addition, there was no difference in lymph node recurrence between N1b group and N1a group (P=0.364), but positive lymph node (PLN) and lymph node positive rate (LNPR) demonstrated a strong discriminatory effect (P<0.001). Conclusion: Lobectomy may be more appropriate for patients with unilateral stage T1 PTC in the low LNPR group.
Multifocal Papillary Thyroid Carcinoma: Clinical Analysis of 168 Cases

Yi-Kai Lin,Jian-Ming Sheng,Wen-He Zhao,Wei-Bin Wang,Xiong-Fei Yu,Li-Song Teng,Zhi-Min Ma

DOI: https://doi.org/10.3760/cma.j.issn.0529-5815.2009.06.016

2009-01-01

Abstract:OBJECTIVE:To investigate the clinical features and treatment of multifocal papillary thyroid carcinoma (PTC).METHODS:A retrospective survey was carried out in 648 patients with PTC who underwent surgery from January 1997 to December 2006. One hundred and sixty-eight cases of the patients presented with multiple tumor masses (> or = 2). The risk factors, including sex of the patients, age at diagnosis, family history of thyroid tumor, multiplicity and bilaterality of tumor, extra-thyroidal extension, lymph node involvement and other were analyzed between solitary PTC and multifocal PTC group.RESULTS:The mean age of the patients was 42 years (range, 14 - 78 years), included 49 male and 119 female. Tumor foci were found in both thyroid lobes in 117 cases (69.6%). Patients with multifocal PTC were characterized by a higher ratio of male (P = 0.004), family history of thyroid tumor (P = 0.031), neck lymph node metastasis (P = 0.008) and extra-thyroidal extension (P = 0.001). However, solitary PTC tended to be with a higher rate of benign goiters in pathologic examination. In multifocal PTC group, male, neck lymphadenectasis, > or = 3 tumor masses or bilaterality of tumor tended to presented with larger tumor, more neck lymph node metastasis and extra-thyroidal extension; And a less malignant tumor in the cases detected with benign goiters in histological examination. By the end of 2007, 164 cases (97.6%) completed follow-up with a mean period of 46.1 months (range, 2 - 127 months), 5 died in the meantime. One patient has been followed-up for 16 months for suspect of lung metastases by chest X-ray. Recurrence occurred in 8 patients and were re-resected, 2 in remnant thyroid and 6 in neck lymph nodes. The overall 1-, 2-, 5-, and 10-year survival rate was 98.2%, 97.4%, 96.5% and 96.5%, respectively. American Joint Committee on Cancer (AJCC) stage was associated with prognosis significantly (chi(2) = 168.832, P = 0.000).CONCLUSIONS:Multifocus is one of the clinical features of PTC and is more malignant than solitary PTC. Total thyroidectomy with central compartment neck dissection could be standard treatment. Lateral nodal dissection is not necessary except for the cases with lymph node metastasis. AJCC stage is still the best prognostic factor.
Impact of different categories of intermediate risk factors on the recurrence of papillary thyroid carcinoma: a retrospective cohort study.

Qiang Chen,Xiuhe Zou,Feng Liu,Anping Su,Yong Jiang,Tao Wei,Rixiang Gong,Jingqiang Zhu,Zhihui Li

DOI: https://doi.org/10.1097/JS9.0000000000001945

2024-01-01

Abstract:BACKGROUND:Data regarding the long-term recurrence in patients with intermediate-risk papillary thyroid carcinoma (PTC) are limited. The aim of this study was to assess the impact of primary tumor-related risk factors and lymph node (LN)-only risk factors on recurrence-free survival (RFS) in patients with intermediate-risk PTC. MATERIALS AND METHODS:Patients with PTC who received initial treatment at our institution between 2010 and 2016 were retrospectively reviewed. A total of 799 intermediate-risk PTC patients were included and further categorized into subgroups according to the different categories of intermediate risk factors. The RFS rates of these subgroups were investigated and compared. RESULTS:Structural recurrence developed in 11 patients (1.4%) of the whole cohort during a median follow-up duration of 96 months. There were no significant differences in RFS between the primary tumor-only risk group and the LN-only risk group, while the combined group of primary tumor risk factors and LN risk factor (metastatic LNs >5) was associated with a worse RFS rate. In the matched-pair analysis, no significant difference in RFS was found between patients who underwent thyroid lobectomy (TL) and those who underwent total thyroidectomy (TT) (6-year RFS: 99.6% vs. 98.8%, P = 0.316) during a median follow-up duration of 100 months. CONCLUSIONS:Intermediate-risk PTC patients who underwent TL had a comparable RFS to those who underwent TT. The combination of primary tumor risk factors and LN risk factor (metastatic LNs >5) may be a useful tool for predicting the risk of long-term structural recurrence in patients with intermediate-risk PTC.
Surgical management and outcomes of T4a papillary thyroid carcinoma: a single-centre study of 602 cases

Yang Liu,Yixuan Song,Yuqin He,Ziren Kong,Han Li,Yiming Zhu,Shaoyan Liu

DOI: https://doi.org/10.1007/s12020-024-04026-5

2024-09-14

Endocrine

Abstract:This study aimed to investigate the clinical characteristics and risk factors associated with the disease progression of T4a papillary thyroid carcinoma (PTC).

endocrinology & metabolism
Initial Surgical Procedure Impact on Prognosis of Papillary Thyroid Carcinoma

WANG Sha-sha,LIN Yan-song,LIANG Jun,CHEN Ge,LI Tian-jun

2012-01-01

Abstract:OBJECTIVE:To analyze the prognosis of papillary thyroid carcinoma(PTC) impacted by initial surgical procedure.METHODS:A retrospective study of 445 patients(329 female,116 male;age:9-68,average age:43 yr)with PTC scheduled for 131I treatment after surgery was conducted.Patients with 1)distant metastasis;2)tumor size≥1 cm;3)tumor 1 cm with extra-capsule invasion or lymph node metastasis were enrolled.Patient's initial surgical procedure varied from total thyroidectomy to nodular dissection and was classified into G1 and G2 groups according to initial surgical procedure adequate or not.Univariate and multivariate analysis of prognostic and tumor-related variables such as:age,gender,initial surgical procedure et al were performed.The self-rating anxiety and depression scales and the economic cost of patients influenced by surgery were also analyzed.RESULTS: Poor prognostic variables were extra-capsule invasion(P=0.001),the frequency of surgery(P0.001),the initial operation pattern(P0.001) by univariate analysis. The frequency of surgery(P0.001) and extra-capsule invasion(P=0.001) were the independent poor prognostic variable by multivariate analysis.Recurrence rate of G2 group were significantly higher than that of G1 group in their follow-up over 3 months,1 year,5 years,10 years,respectively(31.8%/14.1%,χ20.4y=4.49;59.1%/19.6%,χ21y=15.14;63.6%/23.5%,χ25y=13.96;71.2%/26.1%,χ210y=16.47;P0.05).The self-rating anxiety scale(SAS):the average score of G1,G2 was(37.5±8.0) and(40.6±11.26) ponits which were higher than the score of normal Chinese adults(tG1=6.037,tG2=7.068,P0.05),moreover,the SAS score of G2 was significantly higher than that of G1(t=0.534,P=0.000).The self-rating depression scale(SDS):G1 and G2 groups average score were(43.31±10.38) and(46.85 ± 11.86) ponits which were also higher than score of normal Chinese adults(tG1=5.974,tG2=6.466,P0.05).There was a statistical difference between G1 and G2(t=2.574,P=0.017).Re-operation induced by inadequate initial surgery resulted in the additional burden of at least 7 228 RMB on average of each patient,which is 1.8 times than that of every patient who received only one operation(t=6.537,P=0.000).CONCLUSIONS:Initial surgery is a vital factor for the prognosis of PTC.Patients with 1)distant metastasis;2)tumor size≥1 cm;3)tumor 1 cm with extra-capsule invasion or lymph node metastasis should treat total thyroidectomy or near-total thyroidectomy.Inadequate initial surgical procedure causes poor prognosis and have higher recurrence rate as well as added both mental and economic burden to the patients.
Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study

Xiao-Jing Cao,Juan Liu,Ya-Lin Zhu,Lu Qi,Geng Liu,Hong-Ling Wang,Zhong-Hua Wang,Ying Zhou,Jun-Feng He,Jian-Qin Guo,Li-Li Shi,Mei Jian,Aini Shataer,Guo-Zhen Yan,Zhen-Long Zhao,Ying Wei,Li-Li Peng,Yan Li,Ying Che,Shu-Rong Wang,Ming-An Yu

DOI: https://doi.org/10.1210/clinem/dgaa776

2021-01-01

Abstract:Background Ultrasound-guided thermal ablation plays an important role in the management of thyroid disease. The objective of this study was to evaluate the feasibility, efficacy, and safety of thermal ablation for patients with solitary T1bN0M0 papillary thyroid carcinoma (PTC) who are ineligible for or unwilling to undergo surgery. Materials and Methods Data pertaining to 172 patients (38 males and 134 females) who received thermal ablation therapy at 12 hospitals between April 2015 and March 2020 were retrospectively analyzed. The mean duration of follow-up was 24.9 +/- 14.1 months (range, 12-60). The technical feasibility, technical success, efficacy, and safety of treatment were analyzed. Postablation tumor size at various time points was compared with preablation measurement. Results All patients selected for thermal ablation received enlarged ablation, according to contrast-enhanced ultrasound postablation. The maximum diameter and volume of ablation zone at 6, 12, 18, 24, 36, and 48 months postablation were significantly smaller than those recorded preablation (P < 0.05 for all). At the most recent follow-up, 106 (61.6%) tumors had completely disappeared. The rate of lymph node metastasis was 0.6% (1/172) and the incidence of new tumors was 1.2% (2/172). The overall complication rate was 5.2% (9/172) (major complications: 4.6% [8/172]; minor complications: 0.6% [1/172]). All major complications were relieved within 4 months postablation. Conclusion Thermal ablation may be a feasible, effective, and safe treatment option for patients with solitary T1bN0M0 PTC who are ineligible for or unwilling to undergo surgery. It may provide a novel treatment option for selected patients.
The Effect of Hemithyroidectomy in Papillary Thyroid Carcinoma with an Exclusive Involvement of the Recurrent Laryngeal Nerve: A Retrospective Study with a Propensity Score-Matched Analysis

Feng Zhu,Yibin Shen,Lixian Zhu,Linghui Chen,Fuqiang Li,Xiaojun Xie,Yijun Wu

DOI: https://doi.org/10.3390/curroncol31060265

2024-01-01

Current Oncology

Abstract:Background: Involvement of the recurrent laryngeal nerve (RLN) in papillary thyroid carcinoma (PTC) is an important prognostic factor and is associated with a higher risk of recurrence. This study aimed to retrospectively analyze the outcomes of patients treated with hemithyroidectomy (HT) in PTC patients with an exclusive RLN invasion who could not tolerate staged surgery, did not wish to undergo another operation, or had other reasons. Methods: A retrospective review was conducted on 163 patients with PTC and exclusive RLN involvement at our institution between 2013 and 2019. Patients were divided into a total thyroidectomy (TT) group and HT group. The clinicopathologic factors and prognostic outcomes were compared between the two groups. A propensity score-matched analysis was carried out to reduce selection bias, with the following covariates: gender, age, tumor size, multifocality, central lymph node metastasis (CLNM), and RLN resection. The Kaplan-Meier method was used for a comparison of recurrence outcomes. Results: In the baseline data of the 163 PTC patients, tumor size (p < 0.001), multifocality (p = 0.011), CLNM (p < 0.001), and RLN resection (p < 0.008) in the TT and HT groups differed significantly, whereas age and gender did not differ between the two groups. The TT group reported significantly higher temporary and permanent hypoparathyroidism than the HT group (p < 0.001 and p = 0.042, respectively). With 72-month median follow-up, 11 (6.7%) patients developed recurrence. After propensity score matching, 24 patients with HT and 43 patients with TT were included. Recurrence-free survival (RFS) in the matched samples showed no difference between the TT and HT groups (p = 0.092). Conclusion: Our results indicate that HT may be a feasible treatment for PTC patients with exclusive RLN involvement in specific circumstances without significantly increasing the risk of recurrence. Performing a thorough preoperative examination is crucial to exclude multifocal tumors and lymph node metastasis before undergoing HT.
A Comparative Study of Quality of Life in Patients with Papillary Thyroid Carcinoma Undergoing Microwave Ablation Vs. Total Thyroidectomy.

Yan Li,Sheng-Nan Huo,Nai-Cong Lu,Li-li Peng,Ying Wei,Zhen-Long Zhao,Ming-an Yu

DOI: https://doi.org/10.1080/02656736.2023.2250935

2023-01-01

International Journal of Hyperthermia

Abstract:OBJECTIVE:To compare the health-related quality of life (HRQoL) of patients with T1N0M0 papillary thyroid carcinoma (PTC) who underwent microwave ablation (MWA) and those who underwent total thyroidectomy (TT).MATERIALS AND METHODS:From February 2018 to February 2022, 180 T1N0M0 PTC patients were enrolled in present study, including 90 in the MWA group and 90 in the TT group, respectively. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and Thyroid Cancer-Specific Quality of Life Questionnaire (THYCA-QoL) were completed by patients to evaluate their HRQoL scores.RESULTS:According to the results of the EORTC-QLQ-C30, there was a significant difference in the scores of global health, physical, emotional, etc. between the two groups, which indicated that the quality of life in these items in the MWA group was better than those in the TT group (all p < 0.05). According to the results of the THYCA-QoL, all items had significant differences between the two groups except for headache, which demonstrated the thyroid-specific quality of life was higher in the MWA group than in the TT group (all p < 0.05).CONCLUSION:Ultrasound (US)-guided MWA offers a significant advantage in HRQoL over TT in T1N0M0 PTC patients, which provides an important reference for MWA as an alternative strategy to TT.
Long-term follow-up ultrasonography surveillance in a large cohort of patients with papillary thyroid carcinoma

Jing-Wen Zhang,Meng-Jia Fei,Yi-Qing Hou,Zhen-Yun Tang,Wei-Wei Zhan,Jian-Qiao Zhou

DOI: https://doi.org/10.1007/s12020-022-03071-2

Endocrine

Abstract:Objective: This study aimed to investigate the predictive factors as well as the time and age course of recurrence/persistence in a large cohort of postoperative patients with papillary thyroid carcinoma (PTC) based on the long-term ultrasonography (US) follow-up data. Methods: Between January 2007 and December 2016, 3106 patients underwent surgery for PTC and at least two postoperative US follow-up examination over more than three years. Tumor recurrence/persistence was confirmed based on the follow-up US data and histopathological results. Univariate and multivariate analyses were performed to evaluate the predictive factors of tumor recurrence/persistence. Kaplan-Meier survival analysis was used to evaluate the recurrence-/persistence-free survival curve based on the US results. Results: A total of 321(10.3%) patients developed tumor recurrence/persistence during 54.3 months of mean follow-up (range 36-135 months), including 268(83.5%) cases of lymph node recurrence/persistence, 37 (11.5%) cases of non-lymph node recurrence/persistence, and 16(5%) cases of both types. Recurrence/persistence was observed using US examination at a mean interval of 23.6 ± 21.6 months (range 1-135 months) after surgery and peak incidence was observed 1-2 years after initial treatment. Younger (20-30 years old) and older (70-80 years old) patients had a higher proportion of tumor recurrence/persistence. Multifocality, advanced T and advanced N stages were independent risk factors of tumor recurrence/persistence. Conclusion: Tumor recurrence/persistence of PTC usually occurs during the early postoperative period. For patients with multifocal cancer, advanced T and N stage, the US surveillance examination should be cautiously performed, especially in younger and older patients.

Recurrence and postoperative quality of life after surgical resection of unilateral cT1–T3N1bM0 papillary thyroid carcinoma

Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer

Clinical features and prognosis of patients with benign thyroid disease accompanied by an incidental papillary carcinoma.

The outcomes and prognostic factors in patients after reoperation of persistent/recurrent papillary thyroid carcinoma

Status of mental and social activities of young and middle-aged patients after papillary thyroid cancer surgery

The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma

Analysis of Risk Factors Contributing to Recurrence of Papillary Thyroid Carcinoma in Chinese Patients Who Underwent Total Thyroidectomy

Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan

Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study

Quality of Life in Patients with Liver Cancer after Operation:A 2-Year Follow-Up Study

Transition Analysis in the Clinicopathology and Prognosis of 2 682 Papillary Thyroid Carcinoma Cases over a 15-Year Period

Evaluating the risk of re-recurrence in patients with persistent/recurrent thyroid carcinoma after initial reoperation

Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis

Multifocal Papillary Thyroid Carcinoma: Clinical Analysis of 168 Cases

Impact of different categories of intermediate risk factors on the recurrence of papillary thyroid carcinoma: a retrospective cohort study.

Surgical management and outcomes of T4a papillary thyroid carcinoma: a single-centre study of 602 cases

Initial Surgical Procedure Impact on Prognosis of Papillary Thyroid Carcinoma

Efficacy and Safety of Thermal Ablation for Solitary T1bN0M0 Papillary Thyroid Carcinoma: A Multicenter Study

The Effect of Hemithyroidectomy in Papillary Thyroid Carcinoma with an Exclusive Involvement of the Recurrent Laryngeal Nerve: A Retrospective Study with a Propensity Score-Matched Analysis

A Comparative Study of Quality of Life in Patients with Papillary Thyroid Carcinoma Undergoing Microwave Ablation Vs. Total Thyroidectomy.

Long-term follow-up ultrasonography surveillance in a large cohort of patients with papillary thyroid carcinoma